Brain-predicted age in Down syndrome is associated with beta amyloid deposition and cognitive decline

Individuals with Down syndrome (DS) are more likely to experience earlier onset of multiple facets of physiological aging. This includes brain atrophy, beta amyloid deposition, cognitive decline, and Alzheimer's disease—factors indicative of brain aging. Here, we employed a machine learning approach, using structural neuroimaging data to predict age (i.e., brain-predicted age) in people with DS (N = 46) and typically developing controls (N = 30). Chronological age was then subtracted from brain-predicted age to generate a brain-predicted age difference (brain-PAD) score. DS participants also underwent [11C]-PiB positron emission tomography (PET) scans to index the levels of cerebral beta amyloid deposition, and cognitive assessment. Mean brain-PAD in DS participants' was +2.49 years, significantly greater than controls (p < 0.001). The variability in brain-PAD was associated with the presence and the magnitude of PiB-binding and levels of cognitive performance. Our study indicates that DS is associated with premature structural brain aging, and that age-related alterations in brain structure are associated with individual differences in the rate of beta amyloid deposition and cognitive impairment.

[1]  Shashwath A Meda,et al.  Differences in age-related effects on brain volume in Down syndrome as compared to Williams syndrome and typical development , 2014, Journal of Neurodevelopmental Disorders.

[2]  Vincent J. Cunningham,et al.  Parametric Imaging of Ligand-Receptor Binding in PET Using a Simplified Reference Region Model , 1997, NeuroImage.

[3]  C. Iani,et al.  Age‐Related Cortical Thickness Reduction in Non‐Demented Down's Syndrome Subjects , 2016, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[4]  Hong Gu,et al.  Telomere shortening in T lymphocytes of older individuals with Down syndrome and dementia , 2006, Neurobiology of Aging.

[5]  V. Hachinski.  Cerebrovascular Risk Factors , 1986 .

[6]  Paul C. Fletcher,et al.  Obesity associated with increased brain age from midlife , 2016, Neurobiology of Aging.

[7]  K. Macleod,et al.  Biomarkers of oxidative stress are significantly elevated in Down syndrome. , 1998, Free radical biology & medicine.

[8]  Koen L. Vincken,et al.  Brain atrophy and cognition: Interaction with cerebrovascular pathology? , 2011, Neurobiology of Aging.

[9]  Wiepke Cahn,et al.  Accelerated Brain Aging in Schizophrenia: A Longitudinal Pattern Recognition Study. , 2016, The American journal of psychiatry.

[10]  Young T. Hong,et al.  The Down syndrome brain in the presence and absence of fibrillar β-amyloidosis , 2017, Neurobiology of Aging.

[11]  Arno Klein,et al.  Evaluation of 14 nonlinear deformation algorithms applied to human brain MRI registration , 2009, NeuroImage.

[12]  N. Schupf,et al.  Telomere longitudinal shortening as a biomarker for dementia status of adults with Down syndrome , 2016, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[13]  A. Reiss,et al.  Neuroanatomy of Down's syndrome: a high-resolution MRI study. , 2001, The American journal of psychiatry.

[14]  W. Zigman.  Atypical aging in Down syndrome. , 2013, Developmental disabilities research reviews.

[15]  John Ashburner,et al.  A fast diffeomorphic image registration algorithm , 2007, NeuroImage.

[16]  M. Leonardi,et al.  Ageing of people with Down’s syndrome: a systematic literature review from 2000 to 2014 , 2016, International journal of rehabilitation research. Internationale Zeitschrift fur Rehabilitationsforschung. Revue internationale de recherches de readaptation.

[17]  C. Lemere,et al.  Aging in Down Syndrome and the Development of Alzheimer's Disease Neuropathology. , 2015, Current Alzheimer research.

[18]  Robert R. Henry,et al.  Type 2 diabetes mellitus , 2015, Nature Reviews Disease Primers.

[19]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[20]  I. Lott,et al.  Premature aging in persons with Down syndrome: MR findings. , 1996, AJNR. American journal of neuroradiology.

[21]  A. Dale,et al.  One-Year Brain Atrophy Evident in Healthy Aging , 2009, The Journal of Neuroscience.

[22]  S Lovestone,et al.  Brain anatomy and ageing in non-demented adults with Down's syndrome: an in vivo MRI study , 2009, Psychological Medicine.

[23]  G. Heinrich.  Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. , 1989, The New England journal of medicine.

[24]  Stephen M. Smith,et al.  A Bayesian model of shape and appearance for subcortical brain segmentation , 2011, NeuroImage.

[25]  G. Kemp,et al.  Defective Mitochondrial Function In Vivo in Skeletal Muscle in Adults with Down’s Syndrome: A 31P-MRS Study , 2013, PloS one.

[26]  H. Wiśniewski,et al.  Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome , 1985, Annals of neurology.

[27]  Arno Klein,et al.  A reproducible evaluation of ANTs similarity metric performance in brain image registration , 2011, NeuroImage.

[28]  David J. Sharp,et al.  Increased brain-predicted aging in treated HIV disease , 2017, Neurology.

[29]  S. Krinsky-McHale,et al.  Sequence of cognitive decline in dementia in adults with Down's syndrome. , 2000, Journal of intellectual disability research : JIDR.

[30]  Caine W. Wong,et al.  Altered Metabolism of the Amyloid β Precursor Protein Is Associated with Mitochondrial Dysfunction in Down's Syndrome , 2002, Neuron.

[31]  J. Wegiel,et al.  Dementia of the Alzheimer's type and accelerated aging in Down syndrome. , 2005, Science of aging knowledge environment : SAGE KE.

[32]  F. Schmitt,et al.  Cerebrovascular contributions to aging and Alzheimer's disease in Down syndrome. , 2016, Biochimica et biophysica acta.

[33]  C. Melville,et al.  Obesity in adults with Down syndrome: a case-control study. , 2005, Journal of intellectual disability research : JIDR.

[34]  Robert Leech,et al.  Prediction of brain age suggests accelerated atrophy after traumatic brain injury , 2015, Annals of neurology.

[35]  Jonathan D. Power,et al.  Prediction of Individual Brain Maturity Using fMRI , 2010, Science.

[36]  Christos Davatzikos,et al.  Accelerated brain aging in schizophrenia and beyond: a neuroanatomical marker of psychiatric disorders. , 2014, Schizophrenia bulletin.

[37]  C B Harley,et al.  Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. , 1993, American journal of human genetics.

[38]  C. Jack,et al.  Age-specific population frequencies of cerebral β-amyloidosis and neurodegeneration among people with normal cognitive function aged 50–89 years: a cross-sectional study , 2014, The Lancet Neurology.

[39]  Hirokazu Bokura,et al.  Age-related changes in white matter lesions, hippocampal atrophy, and cerebral microbleeds in healthy subjects without major cerebrovascular risk factors. , 2011, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[40]  Manuel Serrano,et al.  The Hallmarks of Aging , 2013, Cell.

[41]  Paul P. Wang.  A neuropsychological profile of Down syndrome: Cognitive skills and brain morphology , 1996 .

[42]  Eileen Luders,et al.  Estimating brain age using high-resolution pattern recognition: Younger brains in long-term meditation practitioners , 2016, NeuroImage.

[43]  Christian Gaser,et al.  Advanced BrainAGE in older adults with type 2 diabetes mellitus , 2013, Front. Aging Neurosci..

[44]  Y. Stern,et al.  Differences between chronological and brain age are related to education and self-reported physical activity , 2016, Neurobiology of Aging.

[45]  Kiralee M. Hayashi,et al.  Plaque and tangle imaging and cognition in normal aging and Alzheimer's disease , 2010, Neurobiology of Aging.

[46]  Stefan Klöppel,et al.  BrainAGE in Mild Cognitive Impaired Patients: Predicting the Conversion to Alzheimer’s Disease , 2013, PloS one.

[47]  D. Mann,et al.  The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome , 1989, Journal of the Neurological Sciences.

[48]  F. Huppert,et al.  The modified CAMDEX informant interview is a valid and reliable tool for use in the diagnosis of dementia in adults with Down's syndrome. , 2004, Journal of intellectual disability research : JIDR.

[49]  Young T. Hong,et al.  The pattern of amyloid accumulation in the brains of adults with Down syndrome , 2016, Alzheimer's & Dementia.

[50]  Nick C Fox,et al.  Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration , 2013, The Lancet Neurology.

[51]  Steve Horvath,et al.  Accelerated epigenetic aging in Down syndrome , 2015, Aging cell.

[52]  Sterling C. Johnson,et al.  The effects of normal aging on amyloid-β deposition in nondemented adults with Down syndrome as imaged by carbon 11–labeled Pittsburgh compound B , 2016, Alzheimer's & Dementia.

[53]  Denise C. Park,et al.  &bgr;-Amyloid burden in healthy aging: Regional distribution and cognitive consequences , 2012, Neurology.

[54]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[55]  G. Small,et al.  Positron emission tomography of brain β-amyloid and τ levels in adults with Down syndrome. , 2011, Archives of neurology.

[56]  Khader M. Hasan,et al.  Prediction of individual subject's age across the human lifespan using diffusion tensor imaging: A machine learning approach , 2013, NeuroImage.

[57]  Hong Gu,et al.  Shorter telomeres may indicate dementia status in older individuals with Down syndrome , 2010, Neurobiology of Aging.

[58]  Luca Tiano,et al.  Mitochondrial dysfunction and Down's syndrome: is there a role for coenzyme Q(10) ? , 2011, BioFactors.

[59]  Sterling C. Johnson,et al.  Cognitive functioning in relation to brain amyloid-β in healthy adults with Down syndrome. , 2014, Brain : a journal of neurology.

[60]  A. Holland,et al.  A four year prospective study of age-related cognitive change in adults with Down's syndrome , 1998, Psychological Medicine.

[61]  F. Huppert,et al.  Population-based study of the prevalence and presentation of dementia in adults with Down's syndrome , 1998, British Journal of Psychiatry.

[62]  Stefan Klöppel,et al.  Estimating the age of healthy subjects from T1-weighted MRI scans using kernel methods: Exploring the influence of various parameters , 2010, NeuroImage.

[63]  G. Alexander,et al.  Relation of medial temporal lobe volumes to age and memory function in nondemented adults with Down's syndrome: implications for the prodromal phase of Alzheimer's disease. , 2002, The American journal of psychiatry.

[64]  Eileen Daly,et al.  Dementia in Down’s syndrome: an MRI comparison with Alzheimer’s disease in the general population , 2013, Journal of Neurodevelopmental Disorders.

[65]  T. Berney,et al.  Fifteen-year follow-up of 92 hospitalized adults with Down's syndrome: incidence of cognitive decline, its relationship to age and neuropathology. , 2007, Journal of intellectual disability research : JIDR.

[66]  H. Möller,et al.  Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometry. , 2004, Brain : a journal of neurology.

[67]  Christian Gaser,et al.  Longitudinal Changes in Individual BrainAGE in Healthy Aging, Mild Cognitive Impairment, and Alzheimer’s Disease , 2012 .